TriSalus Life Sciences, Inc.
TLSIW- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $798.0K in total; no superinvestor holds it.
Other share classesTLSI
13F holders, Q1 2024
Institutional positions in TriSalus Life Sciences, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q4 2023
- Shares held
- 2.59M
- −81.3K (−3.0%) vs. Q4 2023
- Total value
- $3.33M
- −$192.0K (−5.4%) vs. Q4 2023
- New holders
- 3
- 5 more added
- Sold out
- 3
- 4 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLSIW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $798.0K |
| Q1 2026 | 7 | $1.23M |
| Q4 2025 | 8 | $1.77M |
| Q3 2025 | 4 | $337.4K |
| Q2 2025 | 5 | $1.25M |
| Q1 2025 | 6 | $1.11M |
| Q4 2024 | 8 | $1.08M |
| Q3 2024 | 8 | $208.0K |
| Q2 2024 | 19 | $3.71M |
| Q1 2024 | 22 | $3.33M |
| Q4 2023 | 23 | $3.72M |
| Q3 2023 | 20 | $1.20M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding TriSalus Life Sciences, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Magnetar Financial LLC | 767,163 | $843.9K | 0.02% | −112,346−12.8% | Reduced |
| Highbridge Capital Management LLC | – | $662.1K | 0.03% | – | – |
| Deerfield Management Company, L.P. (Series C) | 333,333 | $333.3K | 0.01% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 285,864 | $285.8K | 0.01% | 00.0% | Unchanged |
| Exos Asset Management LLC | 167,610 | $167.6K | 0.10% | +167,610 | New |
| Vestcor Inc | 148,755 | $149.0K | 0.01% | 00.0% | Unchanged |
| MSD Partners, L.P. | 133,333 | $133.3K | 0.01% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 117,290 | $117.3K | 0.00% | +13,540+13.1% | Added |
| Bracebridge Capital, LLC | 92,880 | $92.9K | 0.02% | −5,977−6.0% | Reduced |
| Walleye Capital LLC | 80,883 | $80.9K | 0.00% | +3,840+5.0% | Added |
| Kim, LLC | 79,007 | $79.0K | 0.01% | −10,000−11.2% | Reduced |
| Sequoia Financial Advisors, LLC | 62,187 | $62.2K | 0.00% | 00.0% | Unchanged |
| Aristeia Capital LLC | 53,561 | $58.9K | 0.00% | 00.0% | Unchanged |
| Cowen and Company, LLC | 50,424 | $50.4K | 0.00% | +50,424 | New |
| CastleKnight Management LP | 46,371 | $46.4K | 0.01% | 00.0% | Unchanged |
| Walleye Trading LLC | 45,496 | $45.5K | 0.00% | +2,160+5.0% | Added |
| Clear Street LLC | 41,169 | $41.2K | 0.00% | −9,246−18.3% | Reduced |
| HRT Financial LP | 29,956 | $29.0K | 0.00% | +25+0.1% | Added |
| B & T Capital Management DBA Alpha Capital Management | 22,222 | $22.2K | 0.00% | +22,222 | New |
| Foster Victor Wealth Advisors, LLC | 20,973 | $21.0K | 0.00% | +8,651+70.2% | Added |
| Nomura Holdings Inc | 10,800 | $10.8K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 42 | $42 | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −133,333−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −61,658−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −17,174−100.0% | Sold out |
| Exos TFP Holdings LLC | – | – | – | – | Not filed |